These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Vinca alkaloids, thalidomide and eribulin-induced peripheral neurotoxicity: From pathogenesis to treatment. Islam B; Lustberg M; Staff NP; Kolb N; Alberti P; Argyriou AA J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S63-S73. PubMed ID: 31647152 [TBL] [Abstract][Full Text] [Related]
9. Overview and critical revision of clinical assessment tools in chemotherapy-induced peripheral neurotoxicity. Park SB; Alberti P; Kolb NA; Gewandter JS; Schenone A; Argyriou AA J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S13-S25. PubMed ID: 31647154 [TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy-induced peripheral neuropathy]. Noguchi E; Maeda Y Gan To Kagaku Ryoho; 2011 Nov; 38(11):1773-6. PubMed ID: 22083183 [TBL] [Abstract][Full Text] [Related]
11. [Peripheral neuropathy as a side effect of chemotherapy and targeted therapy]. Gießen-Jung C; von Baumgarten L Dtsch Med Wochenschr; 2018 Jul; 113(13):970-978. PubMed ID: 29972842 [TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin-induced painful neuropathy--flicker of hope or hopeless pain? Stengel M; Baron R Pain; 2009 Aug; 144(3):225-226. PubMed ID: 19477073 [No Abstract] [Full Text] [Related]
14. Mechanisms of Chemotherapy-Induced Peripheral Neuropathy. Zajączkowska R; Kocot-Kępska M; Leppert W; Wrzosek A; Mika J; Wordliczek J Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909387 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced peripheral neuropathy: part 1-current state of knowledge and perspectives for pharmacotherapy. Sałat K Pharmacol Rep; 2020 Jun; 72(3):486-507. PubMed ID: 32394362 [TBL] [Abstract][Full Text] [Related]
16. Acupuncture for chemotherapy-induced peripheral neuropathy (CIPN): a pilot study using neurography. Schroeder S; Meyer-Hamme G; Epplée S Acupunct Med; 2012 Mar; 30(1):4-7. PubMed ID: 22146780 [TBL] [Abstract][Full Text] [Related]
17. Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy. Bakogeorgos M; Georgoulias V Expert Rev Anticancer Ther; 2017 Nov; 17(11):1045-1060. PubMed ID: 28868935 [TBL] [Abstract][Full Text] [Related]
18. Mechanism-based Pharmacological Management of Chemotherapy-induced Neuropathic Pain from Preclinical Studies to Clinical Prospective: Platinum-based Drugs, Taxanes, and Vinca Alkaloids. Zafari N; Velayati M; Maftooh M; Khazaei M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Avan A Curr Pharm Des; 2023; 29(16):1245-1265. PubMed ID: 37190803 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced neuropathy: A comprehensive survey. Miltenburg NC; Boogerd W Cancer Treat Rev; 2014 Aug; 40(7):872-82. PubMed ID: 24830939 [TBL] [Abstract][Full Text] [Related]
20. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Grisold W; Cavaletti G; Windebank AJ Neuro Oncol; 2012 Sep; 14 Suppl 4(Suppl 4):iv45-54. PubMed ID: 23095830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]